Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers

United European Gastroenterol J. 2019 Jun;7(5):682-688. doi: 10.1177/2050640619841989. Epub 2019 Mar 31.

Abstract

Background: Widespread abdominal imaging has led to a substantial increase in the detection of incidentalomas. Currently, an increasing number of centers offer surveillance of the pancreas to individuals at high risk (IARs) of pancreatic ductal adenocarcinoma (PDAC).

Objective: The aims of this study were to evaluate the frequency and type of incidental findings in a magnetic resonance imaging (MRI)-based surveillance program for IARs for PDAC, and to discuss the benefit of detecting these lesions.

Methods: The outcome of MRI screening was reviewed in 568 individuals from three long-term pancreas surveillance programs conducted at three large European expert centers. All MRIs were studied in detail for the presence of incidental lesions.

Results: The most common lesions were liver cysts, renal cysts and liver hemangioma, which together comprised 75% of all lesions. Only five (0.9%) patients underwent surgery for a benign lesion. Cancer was detected in 11 patients (1.9%); early detection of tumors was beneficial in at least five cases.

Conclusion: The present study demonstrates that extrapancreatic incidentaloma is a common finding in IARs for PDAC, but rarely requires additional treatment. CDKN2A-p16-Leiden mutation carriers were the only patient group found to harbor a substantial number of cancers, and detection resulted in benefit in several cases.

Keywords: High-risk individuals; PDAC; genetic predisposition; incidental findings; incidentaloma; screening; surveillance.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Pancreatic Ductal / diagnostic imaging*
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Early Detection of Cancer / methods
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Incidental Findings*
  • Magnetic Resonance Imaging*
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Mutation
  • Pancreatic Neoplasms / diagnostic imaging*
  • Retrospective Studies
  • Risk Factors

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16